132 related articles for article (PubMed ID: 15467439)
1. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.
Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S
Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439
[TBL] [Abstract][Full Text] [Related]
2. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3.
Begum Z; Ghosh A; Sarkar S; Mukherjee J; Mazumdar M; Sarkar P; Chaudhuri S
Glycoconj J; 2004; 20(9):515-23. PubMed ID: 15454689
[TBL] [Abstract][Full Text] [Related]
3. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.
Chaudhuri S; Singh MK; Bhattacharya D; Acharya S; Chatterjee S; Kumar P; Bhattacharjee P; Basu AK; Sa G; Das T; Ghosh TK; Chaudhuri S
J Neurooncol; 2014 Oct; 120(1):19-31. PubMed ID: 25026997
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity.
Mukherjee J; Sarkar S; Ghosh A; Duttagupta AK; Chaudhuri S; Chaudhuri S
Toxicol Lett; 2004 May; 150(3):239-57. PubMed ID: 15110076
[TBL] [Abstract][Full Text] [Related]
5. Disease relevance of T11TS-induced T-cell signal transduction through the CD2-mediated calcineurin-NFAT pathway: Perspectives in glioma immunotherapy.
Chaudhuri S; Bhattacharya D; Singh MK; Moitra S; Ronsard L; Ghosh TK; Chaudhuri S
Mol Immunol; 2015 Oct; 67(2 Pt B):256-64. PubMed ID: 26105805
[TBL] [Abstract][Full Text] [Related]
6. T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.
Chaudhuri S; Singh MK; Bhattacharya D; Datta A; Hazra I; Mondal S; Faruk Sk Md O; Ronsard L; Ghosh TK; Chaudhuri S
J Cell Physiol; 2018 Feb; 233(2):759-770. PubMed ID: 28608562
[TBL] [Abstract][Full Text] [Related]
7. T11TS immunotherapy augments microglial and lymphocyte protective immune responses against Cryptococcus neoformans in the brain.
Hazra I; Sk Md OF; Datta A; Mondal S; Moitra S; Singh MK; Chaudhuri S; Das PK; Basu AK; Dhar I; Basu N; Chaudhuri S
Scand J Immunol; 2019 Feb; 89(2):e12733. PubMed ID: 30450625
[TBL] [Abstract][Full Text] [Related]
8. ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells.
Mukherjee J; Ghosh A; Ghosh A; Chaudhuri S
Cancer Biol Ther; 2006 Feb; 5(2):156-64. PubMed ID: 16357521
[TBL] [Abstract][Full Text] [Related]
9. T11 target structure induced modulations of the pro-inflammatory and anti-infammatorycytokine expressions in experimental animals for glioma abrogation.
Singh MK; Chaudhuri S; Bhattacharya D; Kumar P; Datta A; Chaudhuri S
Int Immunopharmacol; 2015 Feb; 24(2):198-207. PubMed ID: 25528475
[TBL] [Abstract][Full Text] [Related]
10. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation.
Bhattacharjee M; Acharya S; Ghosh A; Sarkar P; Chatterjee S; Kumar P; Chaudhuri S
Int Immunol; 2008 Dec; 20(12):1489-505. PubMed ID: 18931364
[TBL] [Abstract][Full Text] [Related]
11. T11 target structure exerts effector function by activating immune cells in CNS against glioma where cytokine modulation provide favorable microenvironment.
Ghosh A; Bhattacharya M; Sarkar P; Acharya S; Chaudhuri S
Indian J Exp Biol; 2010 Sep; 48(9):879-88. PubMed ID: 21506495
[TBL] [Abstract][Full Text] [Related]
12. T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.
Mondal S; Hazra I; Datta A; Sk Md OF; Moitra S; Tripathi SK; Chaudhuri S
J Cell Physiol; 2018 Jan; 233(1):269-290. PubMed ID: 28233371
[TBL] [Abstract][Full Text] [Related]
13. Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells.
Kumar P; Chatterjee S; Acharya S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2013; 284(1-2):172-81. PubMed ID: 23994239
[TBL] [Abstract][Full Text] [Related]
14. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR.
Mukherjee J; Ghosh A; Sarkar S; Mazumdar M; Sarkar P; Duttagupta AK; Chaudhuri S
Cancer Lett; 2005 May; 222(1):23-38. PubMed ID: 15837538
[TBL] [Abstract][Full Text] [Related]
15. T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.
Bhattacharya D; Singh MK; Chaudhuri S; Datta A; Chaudhuri S
J Cell Physiol; 2017 Mar; 232(3):526-539. PubMed ID: 27255231
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status.
Mukherjee J; Ghosh A; Sarkar P; Mazumdar M; Banerjee C; Chaudhuri S
Anticancer Res; 2005; 25(4):2905-19. PubMed ID: 16080544
[TBL] [Abstract][Full Text] [Related]
17. Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy.
Sarkar S; Begum Z; Dutta S; Dutta SK; Chaudhuri S; Chaudhuri S
J Exp Clin Cancer Res; 2002 Mar; 21(1):95-106. PubMed ID: 12071536
[TBL] [Abstract][Full Text] [Related]
18. T11TS immunotherapy potentiates the repressed calcineurin-NFAT signalling pathway of T cells in Cryptococcus neoformans infected rats: a cue towards T-cell activation for antifungal immunity.
Omar Faruk SM; Hazra I; Mondal S; Datta A; Moitra S; Das PK; Mishra R; Chaudhuri S
J Appl Microbiol; 2020 Sep; 129(3):753-767. PubMed ID: 32145053
[TBL] [Abstract][Full Text] [Related]
19. Akt Phosphorylation Orchestrates T11TS Mediated Cell Cycle Arrest in Glioma Cells.
Acharya S; Chatterjee S; Chaudhuri S; Singh MK; Bhattacharya D; Bhattacharjee M; Ghosh A; Chaudhuri S
Cancer Invest; 2021 Nov; 39(10):854-870. PubMed ID: 34569407
[TBL] [Abstract][Full Text] [Related]
20. A multimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation.
Yamashita K; Parish CR; Warren HS; Harrison LC
Immunology; 1997 Sep; 92(1):39-44. PubMed ID: 9370922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]